Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.
Saved in:
| Title: | Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years. |
|---|---|
| Authors: | Garbe C; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany. claus.garbe@med.uni-tuebingen.de.; Practice Dermatology in Stuttgart, Stuttgart, Germany. claus.garbe@med.uni-tuebingen.de., Keim U; Institute for Health Sciences, University of Tuebingen, Tuebingen, Germany., Amaral T; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany., Ascierto PA; Department of Skin Cancer, Cancer Immunotherapy and Development Therapeutics. Instituto Nazionale Tumouri IRCCS Fondazione G. Pascale, Napoli, Italy., Bauer J; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany.; Practice Dermatology in Stuttgart, Stuttgart, Germany., Dummer R; Department of Dermatology, Aarau, Switzerland.; Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland., Eggermont AMM; University Medical Center Utrecht & Princess Maxima Center, Utrecht, The Netherlands.; Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig Maximilians University, Munich, Germany., Eigentler TK; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany., Flatz L; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany., Forchhammer S; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany., Forschner A; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany., Gandini S; Molecular and Pharmaco-Epidemiology Unit, European Institute of Oncology, IRCCS, Milano, Italy., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany., Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Kirkwood JM; Sandra and Thomas Usher Chair in Melanoma Research, Melanoma and Skin Cancer Program, University of Pittsburgh & UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Lebbe C; Université Paris Cite, AP-HP Dermatooncology and CIC, Cancer institute APHP.nord Paris cité, INSERM U1342, Saint Louis Hospital, Paris, France., Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, Faculty of Medicine & Health, The University of Sydney, Sydney, Australia., Lorigan P; University of Manchester and Christie NHS Foundation, Manchester, UK., Luke JJ; Immunotherapy and Drug Development Center, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA., Meier F; Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases Dresden, Dresden, Germany.; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Metzler G; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany., Nathan P; Mount-Vernon Cancer Centre, Northwood, United Kingdom., Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, and Weill Cornell Medical College, New York City, NY, USA., Robert C; Department of Medical Oncology, Gustave Roussy and Paris Saclay University, Villejuif, France., Röcken M; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany., Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, & German Cancer Consortium, Heidelberg Partner Site Essen, Essen, Germany., Weide B; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany.; Practice Dermatology in Stuttgart, Stuttgart, Germany., Whiteman D; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Leiter U; Center for Dermatooncology, Department of Dermatology, University Hospital of Tuebingen, Tuebingen, Germany., Martus P; Institute for Clinical Epidemiology and Applied Biometrics, University of Tuebingen, Tuebingen, Germany. |
| Source: | Nature communications [Nat Commun] 2026 Jul 02; Vol. 17 (1). Date of Electronic Publication: 2026 Jul 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-026-74443-9 |
